Health ❯ Healthcare ❯ Cancer

Clinical Trials

Patient Outcomes Patient Enrollment Public Perception Patient-Reported Outcomes NHS England Initiatives Outcomes Patient Response Stereotactic Body Radiotherapy Bureaucracy AI in Healthcare

Oral RAS Drug Doubles Survival in Pancreatic Cancer Trial

The result signals a new path against a cancer long resistant to drugs.

NHS England to Offer Abiraterone to High-Risk Prostate Cancer Patients Within Weeks

Study Finds Blood Test Predicts Tarlatamab Benefit in Small Cell Lung Cancer

Mount Sinai Deploys PRISM AI to Match Cancer Patients to Trials Systemwide

AI Multimodal Model Outperforms Oncotype DX for Long-Term Breast Cancer Recurrence Risk

EndRAD Phase 2 Finds Non-TBI Conditioning Matches Outcomes in MRD-Negative Young B-ALL

International NIHR-Backed Trial Launches to Test Aquablation Versus Prostatectomy

Global Consortium Publishes PRO Standards for Cancer Trials and Launches Implementation Toolkit

Lurie Children’s Launches Cal’s Angels Advanced Leukemia Program With $4 Million Gift

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

City of Hope Launches National Clinical Trial Network to Expand Access to Cancer Treatments

Sir Bobby Robson Foundation Unveils £30 Million Cancer Institute Plan in Newcastle

Decipher Prostate Test Identifies Docetaxel Benefit in Metastatic Prostate Cancer

NHS Begins Phase II/III Trial of mRNA Vaccine for Head and Neck Cancer

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Nanoparticle Vaccine Clears Tumors in Over Half of Preclinical Pancreatic Cancer Models

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

Study Reveals Radiotherapy-Induced Protein Drives Tumor Metastasis